Pandemic Antiviral Discovery (PAD) makes first investments to support the development of new antiviral medicines for future pandemics

/in

Fourteen research projects will focus on antiviral research and drug development for henipaviruses, a subgroup of viruses with pandemic potential. Today, the partners in Pandemic Antiviral Discovery (PAD) initiative announced grants totalling more than USD 26 million for 14 research projects aimed at facilitating early-stage development of drugs to treat henipavirus infection and disease in […]

Read more

Prof. Molly Stevens receives the Novo Nordisk Prize – Understanding how materials and biology interact has revolutionised healthcare technologies

/in

Science of small things does not sound like something that can have a big impact on the world, but nanotechnology has proved this is wrong. Tissue engineering, efficient drug delivery and more sensitive screening for diseases are just a few examples. According to Professor Molly Stevens, the new technologies can democratise access to healthcare. She […]

Read more

Novo Holdings participates in Hemab Therapeutics $135M Series B Financing

/in

Hemab Therapeutics is a clinical-stage biotechnology company developing the first prophylactic therapeutics for serious, underserved bleeding and thrombotic disorders Funding enables completion of ongoing Phase 1/2 study of bispecific antibody HMB-001 in Glanzmann Thrombasthenia, initiation of pivotal studies, start and conclusion of Phase 1/2 study of HMB-VWF in von Willebrand Disease, as well as future […]

Read more

Methinks receives CE Marked Certification for AI-based stroke triage software

/in

Methinks Stroke Suite is a disruptive technology that has the potential to provide early, automated detection of large vessel occlusions, both hyperdense and not, from non-contrast computed tomographies BARCELONA, February 21, 2023 – Methinks, a digital health Company that specializes in early detection and management of Acute Stroke (AS), using artificial intelligence (AI), today announced […]

Read more

Zephyrus Innovations announces US FDA approval for its Aeroject™ 3ml safety syringe

/in

Aeroject™ 3ml safety syringe is a single-use, affordable, first generation syringe Aeroject™ has a permanently attached needle system, which upon retraction, fully encases the needle, preventing needle reuse and accidental needlestick The ultra-low wasted space syringes allow for the maximum number of doses to be administered per vial, lowering costs 16 February 2023 – Vancouver, Canada: […]

Read more
© Optimum Strategic Communications.